Jim J Xiao (Jim Xiao)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Venues

Cancer chemotherapy and pharmacology

Clinical pharmacokinetics

Investigational new drugs

European journal of drug metabolism and pharmacokinetics

Clovis Oncology

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Clovis Oncology Feb 15 2015

United States

Sr. Director :: Clinical Pharmacology

Publications

Mingxiang Liao, Jeri Beltman, Heidi Giordano, Thomas C Harding, Lara Maloney, Andrew D Simmons, Jim J Xiao
Clinical Pharmacokinetics and Pharmacodynamics of Rucaparib. Clinical pharmacokinetics 61 (11) (2022)
Mingxiang Liao, Jie Jessie Zhou, Kenton Wride, Denise Lepley, Terri Cameron, Mark Sale, Jim J Xiao
Population Pharmacokinetic Modeling of Lucitanib in Patients with Advanced Cancer. European journal of drug metabolism and pharmacokinetics 47 (5) (2022)
Michelle L Green, Shu Chin Ma, Sandra Goble, Heidi Giordano, Lara Maloney, Andrew D Simmons, Jeri Beltman, Thomas C Harding, Jim J Xiao
Population pharmacokinetics of rucaparib in patients with advanced ovarian cancer or other solid tumors. Cancer chemotherapy and pharmacology 89 (5) (2022)
Nikolay Grechko, Viera Skarbova, Monika Tomaszewska-Kiecana, Rodryg Ramlau, Piotr Centkowski, Yvette Drew, Rafal Dziadziuszko, Milada Zemanova, Jeri Beltman, Eileen Nash, Jenn Habeck, Mingxiang Liao, Jim J Xiao
Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment. Cancer chemotherapy and pharmacology 88 (2) (2021)
Mingxiang Liao, Krzysztof G Jeziorski, Monika Tomaszewska-Kiecana, István Láng, Marek Jasiówka, Viera Skarbová, Piotr Centkowski, Rodryg Ramlau, Maria Górnaś, John Lee, Sarah Edwards, Jenn Habeck, Eileen Nash, Nikolay Grechko, Jim J Xiao
A phase 1, open-label, drug-drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors. Cancer chemotherapy and pharmacology 88 (5) (2021)
Mingxiang Liao, Simon Watkins, Eileen Nash, Jeff Isaacson, Jeff Etter, Jeri Beltman, Rong Fan, Li Shen, Abdul Mutlib, Vendel Kemeny, Zsuzsanna Pápai, Pascal van Tilburg, Jim J Xiao
Evaluation of absorption, distribution, metabolism, and excretion of [14C]-rucaparib, a poly(ADP-ribose) polymerase inhibitor, in patients with advanced solid tumors. Investigational new drugs 38 (3) (2019)

Jim J Xiao.css-eqlu8i{font-size:small;padding-left:4px;} (Jim Xiao)

Publication Activity (10 Years)

Top Topics

Top Venues

Jim J Xiao (Jim Xiao)